Implications of stress-induced genetic variation for minimizing multidrug resistance in bacteria

BMC Medicine

Volumn 10, Issue , 2012, Pages

  Obolski, Uri ^a   Hadany, Lilach ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibiotic resistance; Evolution; HGT; Mathematical model; Stress induced mutagenesis

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; GENETIC VARIABILITY; MATHEMATICAL MODEL; MULTIDRUG RESISTANCE; NONHUMAN; STRESS;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE TRANSFER, HORIZONTAL; GENETIC VARIATION; HOSPITALS; HUMANS; MODELS, BIOLOGICAL; STRESS, PHYSIOLOGICAL;

EID: 84864820635     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-10-89     Document Type: Article

References (53)

1. Bergstrom CT, Feldgarden M. The ecology and evolution of antibiotic resistant bacteria. Evolution in health and disease 1999, 125-138. Oxford University Press, USA, Stephen C Stearns, Jacob C Koella, 2.
2. Wise R, Hart T, Cars O, Streulens M, Helmuth R, Huovinen P, Sprenger M. Antimicrobial resistance. BMJ 1998, 317:609-610. 10.1136/bmj.317.7159.609, 1113826, 9727981.
3. Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 2004, 10:S122-S129. 10.1038/nm1145, 15577930.
4. Kopp BJ, Nix DE, Armstrong EP. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 2004, 38:1377-1382. 10.1345/aph.1E028, 15266044.
5. Hu BJ, Ye HF, Xu YC, Ni YX, Hu YJ, Yu YS, Huang ZF, Ma L. Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China. Curr Med Res Opin 2010, 26:1443-1449. 10.1185/03007991003769068, 20394469.
6. Sjolund M, Wreiber K, Andersson DI, Blaser MJ, Engstrand L. Long-term persistence of resistant enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med 2003, 139:483-487.
7. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE. Trends in antimicrobial drug development: Implications for the future. Clin Infect Dis 2004, 38:1279-1286. 10.1086/420937, 15127341.
8. Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL, Cars O, . ECDC-EMA Working Group Critical shortage of new antibiotics in development against multidrug-resistant bacteria-time to react is now. Drug Resist Updat 2011, 14:118-124. 10.1016/j.drup.2011.02.003, 21435939, ECDC-EMA Working Group.
9. Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997, 24:211-215. 10.1093/clinids/24.2.211, 9114149.
10. Bergstrom CT, Lo M, Lipsitch M. Ecological theory suggests that antimicrobial cycling will not reduce antimicrobial resistance in hospitals. Proc Natl Acad Sci USA 2004, 101:13285-13290. 10.1073/pnas.0402298101, 516561, 15308772.
11. Weinstein MC, Read JL, Mackay DN, Kresel JJ, Ashley H, Halvorsen KT, Hutchings HC. Cost-Effective choice of antimicrobial therapy for serious infections. J Gen Intern Med 1986, 1:351-363. 10.1007/BF02596417, 3098940.
12. Gould IM. A review of the role of antibiotic policies in the control of antibiotic resistance. J Antimicrob Chemother 1999, 43:459-465. 10.1093/jac/43.4.459, 10350373.
13. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001, 134:298-314.
14. Raymond DP, Pelletier SJ, Crabtree TD, Gleason TG, Hamm LL, Pruett TL, Sawyer RG. Impact of a rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit Care Med 2001, 29:1101-1108. 10.1097/00003246-200106000-00001, 11395583.
15. Foucault C, Brouqui P. How to fight antimicrobial resistance. FEMS Immunol Med Microbiol 2007, 49:173-183. 10.1111/j.1574-695X.2006.00172.x, 17181560.
16. Martinez JA, Nicolas JM, Marco F, Horcajada JP, Garcia-Segarra G, Trilla A, Codina C, Torres A, Mensa J. Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units. Crit Care Med 2006, 34:329-336. 10.1097/01.CCM.0000195010.63855.45, 16424711.
17. Masterton RG. Antibiotic cycling: more than it might seem?. J Antimicrob Chemother 2005, 55:1-5. 10.1093/jac/dki044, 15574474.
18. Lipsitch M, Levin BR. Population dynamics of tuberculosis treatment: mathematical models of the roles of non-compliance and bacterial heterogeneity in the evolution of drug resistance. Int J Tuberc Lung Dis 1998, 2:187-199.
19. Bonhoeffer S, Lipsitch M, Levin BR. Evaluating treatment protocols to prevent antibiotic resistance. Proc Natl Acad Sci USA 1997, 94:12106-12111. 10.1073/pnas.94.22.12106, 23718, 9342370.
20. Beardmore RE, Pena-Miller R. Rotating antibiotics selects optimally against antibiotic resistance, in theory. Math Biosci Eng 2010, 7:527-552.
21. Foster PL. Stress-induced mutagenesis in bacteria. Crit Rev Biochem Mol Biol 2007, 42:373-397. 10.1080/10409230701648494, 2747772, 17917873.
22. Bjedov I, Tenaillon O, Gerard B, Souza V, Denamur E, Radman M, Taddei F, Matic I. Stress-induced mutagenesis in bacteria. Science 2003, 300:1404-1409. 10.1126/science.1082240, 12775833.
23. Claverys JP, Prudhomme M, Martin B. Induction of competence regulons as a general response to stress in gram-positive bacteria. Annu Rev Microbiol 2006, 60:451-475. 10.1146/annurev.micro.60.080805.142139, 16771651.
24. Velkov VV. How environmental factors regulate mutagenesis and gene transfer in microorganisms. J Biosci 1999, 24:529-559.
25. Varhimo E, Savijoki K, Jefremoff H, Jalava J, Sukura A, Varmanen P. Ciprofloxacin induces mutagenesis to antibiotic resistance independent of UmuC in Streptococcus uberis. Environ Microbiol 2008, 10:2179-2183. 10.1111/j.1462-2920.2008.01634.x, 18430157.
26. Alonso A, Campanario E, Martinez JL. Emergence of multidrug-resistant mutants is increased under antibiotic selective pressure in Pseudomonas aeruginosa. Microbiology 1999, 145:2857-2862.
27. Perron GG, Hall AR, Buckling A. Hypermutability and compensatory adaptation in antibiotic-resistant bacteria. Am Nat 2010, 176:303-311. 10.1086/655217, 20624092.
28. Kohanski MA, DePristo MA, Collins JJ. Sublethal antibiotic treatment leads to multidrug resistance via radical-induced mutagenesis. Mol Cell 2010, 37:311-320. 10.1016/j.molcel.2010.01.003, 2840266, 20159551.
29. Petrosino JF, Galhardo RS, Morales LD, Rosenberg SM. Stress-induced beta-lactam antibiotic resistance mutation and sequences of stationary-phase mutations in the Escherichia coli chromosome. J Bacteriol 2009, 191:5881-5889. 10.1128/JB.00732-09, 2747895, 19648247.
30. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys JP. Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science 2006, 313:89-92. 10.1126/science.1127912, 16825569.
31. Waldor MK, Beaber JW, Hochhut B. SOS response promotes horizontal dissemination of antibiotic resistance genes. Nature 2004, 427:72-74. 10.1038/nature02241, 14688795.
32. Penades JR, Ubeda C, Maiques E, Knecht E, Lasa I, Novick RP. Antibiotic-induced SOS response promotes horizontal dissemination of pathogenicity island-encoded virulence factors in staphylococci. Mol Microbiol 2005, 56:836-844. 10.1111/j.1365-2958.2005.04584.x, 15819636.
33. Hastings PJ, Rosenberg SM, Slack A. Antibiotic-induced lateral transfer of antibiotic resistance. Trends Microbiol 2004, 12:401-404. 10.1016/j.tim.2004.07.003, 15337159.
34. Hadany L, Beker T. On the evolutionary advantage of fitness-associated recombination. Genetics 2003, 165:2167-2179. 1462912, 14704195.
35. Ram Y, Hadany L. The evolution of stress-induced hypermutation in asexual populations. Evolution 2012, 66:2315-2328. 10.1111/j.1558-5646.2012.01576.x, 22759304.
36. Hadany L, Otto SP. The evolution of condition-dependent sex in the face of high costs. Genetics 2007, 176:1713-1727. 10.1534/genetics.107.074203, 1931531, 17483405.
37. Kermack WO, McKendrick AG. A contribution to the mathematical theory of epidemics. Proc Roy Soc Lond A 1927, 115:700-721.
38. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Microbiology 2010, 156:3216-3223. 10.1099/mic.0.040618-0, 20705661.
39. Gullberg E, Cao S, Berg OG, Ilbäck C, Sandegren L, Hughes D, Andersson DI. Selection of resistant bacteria at very low antibiotic concentrations. PLoS Pathogens 2011, 7:e1002158. 10.1371/journal.ppat.1002158, 3141051, 21811410.
40. Levy SB, Marshall B, Schluederberg S, Rowse D, Davis J. High-frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother 1988, 32:1801-1806. 10.1128/AAC.32.12.1801, 176022, 3266729.
41. OECD Health Data 2012 - Frequently Requested Data. , http://www.oecd.org/document/16/0,3343,en_2649_34631_2085200_1_1_1_1,00.html
42. Paul J. What is the optimal duration of antibiotic therapy?. BMJ 2006, 332:1358. 10.1136/bmj.332.7554.1358, 1476722, 16763248.
43. Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc Natl Acad Sci USA 2000, 97:1938-1943. 10.1073/pnas.97.4.1938, 26540, 10677558.
44. Bassetti M, Righi E, Viscoli C. Pseudomonas aeruginosa serious infections: mono or combination antimicrobial therapy?. Curr Med Chem 2008, 15:517-522. 10.2174/092986708783503186, 18289007.
45. Kouyos RD, Abel zur Wiesch P, Bonhoeffer S. On being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the community. PLoS Pathog 2011, 7:e1001334. 10.1371/journal.ppat.1001334, 3077359, 21533212.
46. Kouyos RD, Abel zur Wiesch P, Bonhoeffer S. Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards. PLoS Comput Biol 2011, 7:e1001094. 10.1371/journal.pcbi.1001094, 3048378, 21390265.
47. Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol 1999, 2:489-493. 10.1016/S1369-5274(99)00005-3, 10508723.
48. Levin BR, Perrot V, Walker N. Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria. Genetics 2000, 154:985-997. 1460977, 10757748.
49. Mc Mahon MAS, Blair IS, Moore JE, Mc Dowell DA. The rate of horizontal transmission of antibiotic resistance plasmids is increased in food preservation-stressed bacteria. J Appl Microbiol 2007, 103:1883-1888. 10.1111/j.1365-2672.2007.03412.x, 17953597.
50. Schafer A, Kalinowski J, Puhler A. Increased fertility of Corynebacterium glutamicun recipients in intergeneric matings with Escherichia coli after stress exposure. Appl Environ Microbiol 1994, 60:756-759. 201381, 8135527.
51. Lee SO, Kim NJ, Choi SH, Kim TH, Chung JW, Woo JH, Ryu J, Kim YS. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents Chemother 2004, 48:224-228. 10.1128/AAC.48.1.224-228.2004, 310160, 14693543.
52. Ho PL, Tse WS, Tsang KWT, Kwok TK, Ng TK, Cheng VCC, Chan RMT. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 2001, 32:701-707. 10.1086/319222, 11229837.
53. Michel JB, Yeh PJ, Chait R, Moellering RC, Kishony R. Drug interactions modulate the potential for evolution of resistance. Proc Natl Acad Sci USA 2008, 105:14918-14923. 10.1073/pnas.0800944105, 2567468, 18815368.